Virus Prevention Claims For RhinoSystems’ Naväge Flushed In Nasal Irrigation Advertising Review

During NAD review, RhinoSystems stated it previously pulled some COVID-19 prevention claims NeilMed challenged and pulled remaining ads after review began. Both RhinoSystems, which markets Naväge brand, and NeilMed, offering a namesake brand, were warned in 2021 by FTC about COVID-19 ad claims.

• Source: Shutterstock

An advertising dispute between two US nasal irrigation device firms was flushed out in a review by an industry self-regulation group, which found that one made unsupported virus prevention claims in TV and radio commercials.

BBB National Program Inc.’s National Advertising Division (NAD) reports that during its review, the firm, RhinoSystems Inc., stated that it...

Welcome to Medtech Insight

Create an account to read this article

More from Compliance

More from Policy & Regulation

EUDAMED Notice Anticipated By September As Commission Optimizes Operations

 

The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.

From Imitation To Action: Johns Hopkins Robot Autonomously Performs Key Step In Gallbladder Surgery

 
• By 

Researchers at Johns Hopkins have used a robotic system to autonomously perform a key part of gallbladder surgery without a surgeon's hand. Lead author Axel Krieger says it could take five to 10 years before an autonomous robotic system will reach human trials and expects regulatory hurdles.

Remote Regulatory Assessments Become Swiss Army Knife For US FDA’s Oversight Of Facilities

 

“RRAs are valuable oversight tools and under certain circumstances, can assist FDA in its mission to protect public health, oversee regulated industry, and help ensure regulated products comply with FDA requirements,” according to final guidance.